Video above: Biogen Alzheimer’s drug receives big boost from FDAThe U.S. Food and Drug Administration soon will consider whether to approve a new Alzheimer’s drug for the first time in almost two decades.The agency’s Peripheral and Central Nervous System Drugs Advisory Committee will meet on Friday to discuss aducanumab, an experimental treatment administered through intravenous infusion for early Alzheimer’s disease. The treatment was developed by